Stocks · Korea
115450
KOSDAQ
HLB Therapeutics
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+13.57%
1M+39.86%
3M+34.71%
6M-4.56%
1Y-8.06%
YTD-0.78%
52W high4,160원
52W low1,342원
From 52W high-29.57%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 481억 | -79억 | -121억 | -16.4% |
| 2023 | 537억 | -87억 | -31억 | -16.2% |
| 2024 | 549억 | -76억 | -235억 | -13.9% |
| 2025 | 696억 | -35억 | -97억 | -5.1% |
| Quarterly | ||||
| 2024 4Q | 165억 | 37,060,134원 | 18억 | 0.2% |
| 2025 1Q | 150억 | -16억 | -45억 | -10.5% |
| 2025 2Q | 157억 | -7억 | -38,902,352원 | -4.2% |
| 2025 3Q | 161억 | -54억 | -56억 | -33.5% |
| 2025 4Q | 228억 | 41억 | 5억 | 18.0% |
| 2026 1Q | 130억 | -32억 | -44억 | -24.8% |
Company
Address: 경기도 구리시 산마루로 6 2층 202호
Peers in the same sector
Recent filings
- 2026-08-21[기재정정]주요사항보고서(자기전환사채만기전취득결정) Major
- 2026-08-21[기재정정]주요사항보고서(유상증자결정) Major
- 2026-08-21[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-08-21[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-08-13반기보고서 (2026.06)
- 2026-08-07주요사항보고서(자기전환사채만기전취득결정) Major
- 2026-08-07주요사항보고서(유상증자결정) Major
- 2026-08-07[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-08-07[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.